Thrive Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Thrive Capital
- 1(12 months)
- thrivecap.com
- Update Information
More venture news
- 16 Jul 2026
Risk LedgerRisk Ledger unlocks £20m Series B led by Axiom Equity to deliver network-first supply chain security platform
Series BCybersecurity - 9 Jul 2026
Kraken Technology GroupKraken Technology Group unlocks £130m Series B round led by DTCP for its uncrewed surface vessels and maritime defence platforms
Series BDefence - 8 Jul 2026
FleekFleek raises £19m Series B led by Burda Principal Investments to build AI infrastructure for the secondhand clothing supply chain
Series BSupply Chain
